What Next | Daily News and Analysis

TBD | The AstraZeneca Saga

03.26.2021 - By Slate PodcastsPlay

Download our free app to listen on your phone

Download on the App StoreGet it on Google Play

Back in April 2020, AstraZeneca was hailed as a frontrunner in the race to get an effective vaccine to market. A year later, after a series of trial pauses, communication blunders, and PR problems, the vaccine is on the cusp of FDA approval. 

By all accounts, the company succeeded in making a safe, effective vaccine. So why has there been so much confusion about its rollout?

Guest: 

 

Peter Aldhous, science reporter at Buzzfeed News

Host

Lizzie O’Leary

 

Learn more about your ad choices. Visit megaphone.fm/adchoices

More episodes from What Next | Daily News and Analysis